|  Help  |  About  |  Contact Us

Publication : CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells.

First Author  Chen Z Year  2011
Journal  J Exp Med Volume  208
Issue  13 Pages  2633-40
PubMed ID  22143889 Mgi Jnum  J:179048
Mgi Id  MGI:5301013 Doi  10.1084/jem.20102575
Citation  Chen Z, et al. (2011) CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells. J Exp Med 208(13):2633-40
abstractText  Although carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) has been viewed as a tumor suppressor, increasing clinical evidence shows that high levels of CEACAM1 expression on tumors correlates with poor prognosis and high risk of metastasis. Here, we examined the consequences of CEACAM1 expression on tumor cells. We show that tumor cell-associated CEACAM1 causes intracellular retention of various NKG2D ligands in mouse and human tumor cells. CEACAM1-silenced tumor cells expressed more cell surface NKG2D ligands and exhibited greater sensitivity to natural killer cell-mediated cytolysis in vitro and rejection in vivo. Our studies reveal a novel mechanism through which CEACAM1-bearing tumor cells may escape immune-surveillance.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

4 Bio Entities

Trail: Publication

0 Expression